CyTOF analysis of melanoma treated with ICIs showed that the abundance of CD69+ and MIP1β+ NK cells [101] and CD14+CD16−HLA-DRhi cells [102] were predictive biomarkers of response to anti-PD-1 therapy. Here, PDCD1 is linked to melanoma.